| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_47bdaff29c03c5db5f48b8f1827878b8 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-30 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-30 |
| filingDate |
1996-10-18^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_460b2fd31247696b78afb5d880df9989 |
| publicationDate |
1997-05-07^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
GB-2306324-A |
| titleOfInvention |
A composition for the treatment of herpes infections comprising acyclovir and zinc |
| abstract |
A composition intended for the treatment of herpes infections comprises acyclovir and zinc, preferably a salt thereof such as zinc sulphate or zinc oxide, more preferably zinc linoleate. The composition may be administered orally but preferably is present in the form of a topical ointment and may include other antiviral agents such as 1-aminoadamantanehydrochloride and also a copper salt. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2283805-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2316415-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-02056913-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-02056913-A2 |
| priorityDate |
1995-10-19^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |